STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer

NCT06574880 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Malignant Neoplasm of Prostate
Locally Advanced Prostate Cancer

Interventions

DRUG: Lu-PSMA-617
RADIATION: 5-fraction Stereotactic Body Radiation Therapy (SBRT)

Sponsor

Angela Y. Jia, MD PhD